Accordingly, we prospectively recruited a cohort of treatment-naïve CLL patients to simultaneously evaluate global skeletal volume (SV) and structure, active bone marrow (RBM) distribution and metabolism as well as clonal activation by RANK/RANKL pathway. Here, TNFRSF11A is linked to B-cell chronic lymphocytic leukemia.